14:22:30 EDT Fri 14 Jun 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Diagnos Inc (3)
Symbol ADK
Shares Issued 75,684,300
Close 2024-04-02 C$ 0.32
Market Cap C$ 24,218,976
Recent Sedar Documents

Diagnos appoints Couillard as director

2024-04-02 13:56 ET - News Release

Mr. Andre Larente reports

DIAGNOS WELCOMES DR. PHILIPPE COUILLARD TO ITS BOARD OF DIRECTORS

Diagnos Inc. has appointed Dr. Philippe Couillard to the corporation's board of directors.

Seasoned business adviser, neurosurgeon and former university professor, Dr. Couillard served as Premier of the province of Quebec from 2014 to 2018. Between 2003 and 2008, he was the province of Quebec's Minister of Health and Social Services. Today, Dr. Couillard acts as strategic adviser to Canadian and international organizations.

"We are pleased that Philippe has accepted to join the board. We strongly believe that his impressive and unique work experience, combined with his training as medical doctor, will be instrumental in the strategic development and governance of our business," said Andre Larente, president of Diagnos.

Dr. Couillard stated: "In my opinion, Diagnos is a very good example of how health care organizations could positively benefit from AI [artificial intelligence] technologies. I look forward to contribute to the success of Diagnos, and work with my fellow directors and the management."

Dr. Couillard's directorship became effective April 1, 2024.

About Diagnos Inc.

Diagnos is a publicly traded Canadian corporation dedicated to early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications such as CARA (computer-assisted retina analysis). CARA's image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.